1. Home
  2. NEO vs BFS Comparison

NEO vs BFS Comparison

Compare NEO & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • BFS
  • Stock Information
  • Founded
  • NEO 2001
  • BFS 1993
  • Country
  • NEO United States
  • BFS United States
  • Employees
  • NEO N/A
  • BFS N/A
  • Industry
  • NEO Precision Instruments
  • BFS Real Estate Investment Trusts
  • Sector
  • NEO Health Care
  • BFS Real Estate
  • Exchange
  • NEO Nasdaq
  • BFS Nasdaq
  • Market Cap
  • NEO 963.9M
  • BFS 830.6M
  • IPO Year
  • NEO 1999
  • BFS 1993
  • Fundamental
  • Price
  • NEO $5.10
  • BFS $32.25
  • Analyst Decision
  • NEO Buy
  • BFS Strong Buy
  • Analyst Count
  • NEO 8
  • BFS 1
  • Target Price
  • NEO $12.14
  • BFS $45.50
  • AVG Volume (30 Days)
  • NEO 2.3M
  • BFS 57.0K
  • Earning Date
  • NEO 07-29-2025
  • BFS 08-12-2025
  • Dividend Yield
  • NEO N/A
  • BFS 7.32%
  • EPS Growth
  • NEO N/A
  • BFS N/A
  • EPS
  • NEO N/A
  • BFS 1.47
  • Revenue
  • NEO $689,189,000.00
  • BFS $274,011,000.00
  • Revenue This Year
  • NEO $13.83
  • BFS $10.48
  • Revenue Next Year
  • NEO $11.35
  • BFS $6.52
  • P/E Ratio
  • NEO N/A
  • BFS $21.93
  • Revenue Growth
  • NEO 9.70
  • BFS 5.04
  • 52 Week Low
  • NEO $4.81
  • BFS $31.25
  • 52 Week High
  • NEO $19.12
  • BFS $42.39
  • Technical
  • Relative Strength Index (RSI)
  • NEO 24.08
  • BFS 35.67
  • Support Level
  • NEO $4.81
  • BFS $32.65
  • Resistance Level
  • NEO $6.61
  • BFS $33.60
  • Average True Range (ATR)
  • NEO 0.37
  • BFS 0.64
  • MACD
  • NEO -0.15
  • BFS -0.15
  • Stochastic Oscillator
  • NEO 10.86
  • BFS 2.65

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

Share on Social Networks: